Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Associate Director, Global Production Planning & Inventory Control Job
Celgene Corporation - Basking Ridge, NJ, US
Analyst, Procurement Operations Job
Celgene Corporation - Basking Ridge, NJ, US
Principal Scientist
Watson Pharmaceuticals - Fort Lauderdale, FL
Partner
Lundbeckfond Ventures - Copenhagen, Denmark
Manager, Strategic Forecasting & Analytics Job
Celgene Corporation - Basking Ridge, NJ, US

More Jobs >>

Events

CHI's Summit for Clinical Ops Executives (Scope)
February 7-9 — Miami
Life Science in the Cloud
Nov 16, 2011 — Cambridge, MA
Enforcement, Litigation and Compliance Conference
Dec. 6-7 — Washington, DC
New Paradigms to Fund & Move Biotech
January 11-12, 2012 — San Francisco, CA

More Events >>

Related Tags >> swine flu stockpile H1N1 Novartis

France News

Most Popular France Story

Vaccine makers settle France's H1N1 bill

March 25, 2010 — 7:07am ET | By John Carroll

A newspaper has reported that France has struck a deal to pay several large vaccine makers just 16 percent of the amount it had contracted to pay after canceling a huge order of swine flu vaccine. Read more...

France Press Releases

Actavis launches Finasteride as patent expires in France
Ambrilia Biopharma Provides an Update on Reduction of Operations in France and on Review of Strategic Alternatives

Latest Headlines

Vaccine makers settle France's H1N1 bill
March 25, 2010
Countries place huge vax orders, ready campaigns
July 16, 2009

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK